Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

CMI Media Group Bolsters Innovative Capabilities with Audience Intelligence Group for Pharma and Healthcare Clients


Photo of Liz McShea, Group VP, Fabian Henault, VP, Market Research, and Rick Johnson, VP, Intelligence Solutions, leading CMI Media Group's Audience Intelligence Practice.

The leadership team of CMI Media Group’s Audience Intelligence Practice includes Liz McShea, Group VP, Fabian Henault, VP, Market Research, and Rick Johnson, VP, Intelligence Solutions.

“Our industry often talks about improving patient outcomes and in evolving our Audience Intelligence group we’ve been able to walk the walk,” said Julie Hurvitz Aliaga, EVP, Innovation, Content and Partnerships.

CMI Media Group, a WPP company (NYSE: WPP), has evolved its Audience Intelligence practice to holistically connect audience strategy, marketing/ad research, social intelligence, and data insights further enabling always on-intelligence that drives dynamic content, media-mix optimization and deeper engagements. With a focus on driving clients towards where innovation and data intersect, this forward-thinking mentality will continue to position the company as the leader in precisely human insight and activation. The company has made several key hires and promotions to support the practice.

“Our industry often talks about improving patient outcomes and in evolving our Audience Intelligence group we’ve been able to walk the walk. By ensuring every decision is driven by human insights from the start, we can help our clients to provide their patients and HCPs with what they need and want, often before they themselves recognize that need. We’re reaching the holy grail,” said Julie Hurvitz Aliaga, EVP, Innovation, Content and Partnerships. The evolution of stand-alone departments into one holistic group with strategic leadership sends innovation to the forefront by bringing real-time social and attitudinal data together.

Leading the practice is Liz McShea in the role of Group VP, Audience Intelligence. McShea has deep experience in research and social intelligence, having worked on the vendor side at ListenLogic, and later took her passion and skills for research and healthcare to AstraZeneca, where she was instrumental in building their social intelligence practice, a first for the organization. Now with CMI Media Group, McShea is taking all her knowledge of the vendor and client spaces to move research forward for clients. With McShea’s leadership and vast knowledge of the media landscape, the organization will be able to ensure research leads to media KPIs and keeps media outcomes top of mind.

Joining McShea in leadership is Rick Johnson, who will focus on Market Research and Social Intelligence team management as VP, Intelligence Solutions. In his role, Johnson will ensure the Market Research and Social Intelligence teams continue to deliver opportunities leveraging the organization’s best-in-class tools, such as CheckUp and Media Vitals(TM) research, which have become the gold standard for strategic healthcare audience insights and implementation of innovative approaches. Previously with Aetna/CVS Health, Johnson will continue to expand opportunities for the organization and connect the Market Research to Social Intelligence pillars more closely, threading the needle between research and social data. Rounding out leadership in the group is Fabian Henault, VP, Market Research. As a trusted leader since 2020, Henault will continue to leverage his expansive knowledge and expertise in every aspect of research important to clients to ensure insightful and impactful deliverables.

“Our Audience Intelligence Practice brings unmatched human-centered capabilities to our healthcare clients and enables them to truly put their patients and HCPs at the center at the center of everything they do, while delivering on health and business KPIs,” said Dr. Susan Dorfman, President and CEO, CMI Media Group.

About CMI Media Group

CMI Media Group, a WPP company (NYSE: WPP, http://www.wpp.com), is a full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and Insights; Data and Analytics; Buying and Investment; and Direct Response and Customer Experience. As the leading media resource for the world’s top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients. CMI Media Group has been recognized as a leader in DE&I, talent retention and employee development as well as one of the industry’s best places to work. To apply for a position within our teams visit https://cmimediagroup.com/careers/

Share article on social media or email:

Leva Clinic, chronic pain and medical cannabis leaders, raise $3.5m to transform treatment for UK pain patients


“Leva’s unique patient centric platform is delivering for our patients, and with this investment we intend to further increase our reach across the UK and continue to build our offering through digital access.”Eric Bystrom, Leva co-founder and CEO

Leva Clinic has announced that it has secured $3.5m USD (£3m GBP) of funding from Óskare Capital and Justin Hartfield to accelerate innovation in medical cannabis therapeutics and scale the delivery of digital solutions for chronic pain patients.


  • Leva Clinic (“Leva”) operates the UK’s first online clinic for chronic pain, owns one of the UK’s leading brands of medical cannabis (Satoline), and is a founding member of the largest observational medical cannabis study in the UK (Project Twenty21)
  • Justin Hartfield, founder of Weedmaps, one of the world’s largest integrated cannabis technology platforms, has led a $3.5m USD (£3m GBP) investment in Leva alongside Óskare Capital, a European medical and pharmaceutical cannabis fund.
  • Funding will grow the clinic’s reach, strengthen and broaden partnerships with the NHS and other healthcare providers, and improve ongoing patient experience with a mobile app.

One quarter of adults in the UK are living with a pain condition that has lasted over three months, with chronic pain having been dubbed a “silent epidemic”. Pain costs the UK economy significantly more than cancer and heart disease, almost as much as diabetes and obesity costs. A lack of personalised treatment options and difficulties in accessing clinical support currently prevents millions of adults from living a life without pain, and fueling a surge in opioid-related deaths.

Established in 2019, Leva Clinic is the UK’s first online clinic for people living with chronic pain. Regulated by the Care Quality Commission. Leva’s services are accessible through the Boots Health Hub, and the clinic also has live partnerships with several NHS trusts to deliver digital therapeutic services and consultant-led patient care plans.

Justin Hartfield, who founded global cannabis technology platform Weedmaps in 2008, makes the investment via his private investment office 2420 Partners. The investment is the first for 2420 in the UK and the second in Europe. He said:

“Our investment in Leva is perfectly aligned with our goal to support emerging businesses in the pain management space globally. Leva is on the path to being a market leader in delivering innovative pain management solutions by industry-leading pain experts in the UK. We are excited to partner with the company in its next chapter of growth.”

Leva is a founding member of Project Twenty21, the largest observational medical cannabis study in the UK. Leva’s Satoline range of medical cannabis-based medicines is part of the formulary for the trial, gathering evidence on the efficacy of medical cannabis-based medicines.

Leva is also one of three suppliers participating in the ‘I Am Billy’ Foundation RESCAS program (Refractory Epilepsy Specialist Clinical Advisory Service), set up in 2020 following a legal challenge brought by campaigner Charlotte Caldwell against the UK government. It provides a much-needed route to NHS-funded medical cannabis for people under the age of 18 affected by refractory epilepsy.

Leva co-founder and CEO Eric Bystrom said:

“Leva’s unique patient centric platform is delivering for our patients, and with this investment we intend to further increase our reach across the UK and continue to build our offering through digital access. Justin’s experience in developing digital offerings coupled with Oskare’s life sciences expertise make them the perfect partners for this next stage of our journey.”

Óskare Capital is a European medical and pharmaceutical cannabis fund, unlocking the endocannabinoid system through Life Sciences and Deep Tech.

Dr John Rogers, Neurologist and co-founder of Óskare, on joining Leva’s board said:

We have been impressed by Leva’s approach to patient care, also affirmed by their NHS contracts and recent CQC report. Leva has assembled a highly experienced team of pain management experts, and we are excited to help Leva make these patient services available across the UK.”

Oliver Lamb, Co-Founder and Investment Manager at Óskare Capital, said:

“We are excited about our investment in Leva and their much needed pain management platform. One of the key issues that Óskare Capital seeks to address in the medical cannabis market is patient access, and Leva are breaking down the barriers for those patients most in need. Having been in discussions with the Leva team for over a year, we have been continually impressed by their vision and dedication.”

Dr Arun Bhaskar, Consultant in Pain Medicine and President of the British Pain Society, will also join the board as an independent director. He adds:

“The dedication of the team to both best clinical practice and patient care is resulting in excellent patient outcomes”

ENDS

Share article on social media or email:

Chris Duignan Joins Flourish Research as Chief Financial Officer


Photo of Chris Duignan, CFO of Flourish Research

Chris Duignan, CFO of Flourish Research

“I’m excited to join the Flourish team and work with top-notch, seasoned pharmaceutical services professionals during this time of company-wide growth.” -Chris Duignan, CFO

Chris Duignan has been named Chief Financial Officer of Flourish Research, a diversified clinical trial company designed to acquire, operate, and integrate large, best-in-class clinical research sites with expertise in studies spanning Phases I-IV.

Mr. Duignan will build the financial infrastructure, lead financial operations, and integrate the acquisitions of the rapidly growing organization. He is a highly experienced senior financial executive with more than 25 years of public and private company experience, including 14 years in the life sciences industry.

Mr. Duignan was most recently a VP of Finance at an independent clinical research network comprised of 21 wholly owned clinical sites. Chris previously spent six years as the VP of Finance at the New York Genome Center, building the financial architecture of the DNA sequencing center.

“Chris brings with him a deep understanding of our industry and the ability to leverage financial management and reporting to help research sites thrive,” said Reinhold Schulz, Chief Executive Officer of Flourish. “We are fortunate to have him on the leadership team to guide us during our time of expansion.”

Chris Duignan stated, “I’m excited to join the Flourish team and work with top-notch, seasoned pharmaceutical services professionals during this time of company-wide growth.”

Mr. Duignan spent the first four years of his career at PricewaterhouseCoopers, holds a Bachelor of Science in Accounting from Fairfield University, and spent six years in the Marine Corps Reserves.

About Flourish Research:

Flourish Research is a leading clinical trial organization, created to strategically acquire, create, and operate the best clinical trial sites in North America. Flourish sites started as some of the most recognized trial sites in the industry including Clinical Trials of Texas, Excel Medical Clinical Trials, Clinical Sites Partners, Keystone Clinical, and Great Lakes Clinical Trials.

Flourish sites conduct Phase I-IV studies across therapeutic areas where they have deep expertise, including Cardiology/Metabolic Disease/Renal, CNS, Pulmonology and Vaccines. Flourish key investigators are full-time, dedicated to research at sites that are large and highly experienced.

Share article on social media or email:

SmartTRAK Advances Medtech Market Insights Platform; Announces New Modules for Wound Care and Orthopedic/Spine Injectables


SmartTRAK Logo

“SmartTRAK has a long history of being the trusted source for our clients … We are continuously expanding the SmartTRAK platform to cover new and emerging markets of high value to our subscribers and offer unique and differentiated analytical tools.” – Sharon O’Reilly, CEO

SmartTRAK, the leading global Medtech business and market insights platform in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets, announces the expansion of its solutions portfolio focused on new market coverage for Wound Debridement and Injectables for spinal disc degeneration and osteoarthritis (OA) of the knee.

SmartTRAK is an Insights-as-a-Service platform that equips customers with real-time, accurate market, company and product insights from hundreds of carefully curated data sources. The solution includes rich content provided through a SaaS platform and includes daily updates, tools and dashboards along with direct access to market analysts and expert advisory services.

Wound Debridement, a newly covered segment offered on the SmartTRAK platform, is foundational to wound healing and the success of every advanced wound care product. According to Wound Care market expert and General Manager Gary Delhougne, “our new module will cover the full scope of the debridement market opportunity and will be beneficial to companies directly participating or contemplating entering into the debridement space.” The Wound Debridement module is now widely available to customers.

SmartTRAK is addressing the explosive growth in the Injectables arena, specifically in the areas of osteoarthritic knee pain, discogenic back pain and degenerative disc disease. According to Elise Wolf, General Manager of Orthopedics and Enabling Technologies, “the potential US market for Disc Injectables is over $50B annually, while the next generation OA Injectables exceeds $10B annually. Our market experts have been keeping a finger on the pulse of this dynamic growth sector and clients can now leverage the SmartTRAK platform for strategic planning and product development related to injectable technologies.” The Disc Injectables module is currently available and the Knee OA module will be launched by the end of 2022.

“SmartTRAK has a long history of being the trusted source for our clients for relevant, up-to-date and comprehensive market coverage and critical insights for strategic decision-making,” says CEO Sharon O’Reilly. “We are continuously expanding the SmartTRAK platform to cover new and emerging markets of high value to our subscribers and offer unique and differentiated analytical tools that help our customers innovate while achieving economies of scale with one comprehensive solution. The Debridement and Injectables market expansions are examples of how SmartTRAK helps our customers stay on the forefront of market advancements.”

SmartTRAK is innovating to serve the business intelligence needs for more than 75 global Medtech customers, which include most of the leading Orthopedic and Wound Care companies. “We have an aggressive product roadmap that includes further expansion into new markets as well as significant investment in developing a new suite of Data Insights tools for product, procedure, pricing and sales targeting built off of granular data sources,” shares Chief Growth Officer Linda Bernier. “Our customers are drowning in clunky data files and consistently look to SmartTRAK as their primary source for meaningful insights and real-time tools that can be accessed 24×7 by leaders across their enterprise.”

Starting in 2023, SmartTRAK will also be offering customers new capabilities for tracking and analyzing the Ambulatory Surgical Center (ASC) market along with other tools that offer strategic insights from CMS and other publicly available and commercial data sources.

About SmartTRAK

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. For more information visit http://www.SmartTRAK.com and follow us on LinkedIn.

Share article on social media or email:

COFEPRIS Certifies Valeo II™ Silicon Nitride Interbody Line


CTL Amedica is the world’s exclusive provider of silicon nitride spine products.

The Valeo II silicon nitride interbody line provides many advantages for surgeons and their patients, and we are thrilled to start marketing the devices in Mexico.

The Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), the agency charged with overseeing the quality of medical devices and products made in and imported into Mexico, has certified the registration of CTL Amedica Corporation’s Valeo II™ silicon nitride interbody line. The registration was made with the assistance of registration partner Minimal Medics S.A de C.V.; and the certification will enable CTL Amedica to commercialize and market the Valeo II silicon nitride interbody line in Mexico.

“The Valeo II silicon nitride interbody line provides many advantages for surgeons and their patients, and we are thrilled to start marketing the devices in Mexico. Silicon nitride is the only material to provide osteointegration, bacteriostatic properties and excellent imaging quality. This is important medical technology and we’re grateful for the opportunity to make it readily accessible in Mexico,” said Daniel Chon, CEO of CTL Amedica.

The certification includes the following Valeo II devices:

  • Valeo II C, Anterior Cervical Interbody Fusion Device
  • Valeo II OL, Bulleted Transforaminal Lumbar Interbody Fusion Device
  • Valeo II TL, Curved Transforaminal Lumbar Interbody Fusion Device
  • Valeo II AL, Anterior Lumbar Interbody Fusion Device
  • Valeo II LL, Lateral Lumbar Interbody Fusion Device

Valeo II interbody devices are made entirely of silicon nitride, an ideal biomaterial. Silicon nitride’s surface chemistry and natural nanostructure topography provide an optimal environment for new bone growth and contribute to its inherent, bacteriostatic behavior. CTL Amedica is the world’s exclusive provider of silicon nitride spine products.

In addition, the Valeo II interbody line is semi-radiolucent with clearly visible boundaries and the products produce no distortion under MRI, as well as, no scattering under CT. These favorable imaging qualities enable a precise view of the implants’ operative placement and postoperative fusion assessment.

CTL Amedica is a forward-thinking medical device design, development and manufacturing company. CTL Amedica maintains a Texas-based headquarters and in-house manufacturing facility, along with a Pennsylvania-based R&D Center of Excellence. A leader in the medical device technology and biomaterials space, CTL Amedica provides a full line of cervical, thoracic and lumbar fusion and fixation products. For more information, visit https://www.ctlamedica.com/.

Share article on social media or email:

American College of Lifestyle Medicine Designates the Ardmore Institute of Health’s Full Plate Living Program a Certified Lifestyle Medicine Program


News Image

More people are living healthier lives and feeling great because of Full Plate Living and the Ardmore Institute’s passion for a future where healthy lifestyles are the preferred method to prevent, treat and reverse chronic diseases.

The American College of Lifestyle Medicine (ACLM) today announced that the Ardmore Institute of Health’s (AIH) Full Plate Living program has earned Certified Lifestyle Medicine Program designation. The designation recognizes, supports and encourages the adoption of evidence-based health intervention programs that meet rigorous review requirements and standards for offering lifestyle modification to address chronic disease.

Lifestyle medicine is a medical specialty that uses therapeutic lifestyle interventions as a primary modality to treat chronic conditions including, but not limited to, cardiovascular diseases, type 2 diabetes, and obesity. Lifestyle medicine-certified clinicians are trained to apply evidence-based, whole-person, prescriptive lifestyle change to treat and, when used intensively, often reverse such conditions. Applying the six pillars of lifestyle medicine—a whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connections—also provides effective prevention for these conditions.

Full Plate Living is a nutrition education program provided as a free service by AIH. The program helps people add more whole, unprocessed fiber foods into their diet — a friendly approach to diet improvements that can lead clients to meaningful changes in their health.

About 90 percent of Americans fail to meet the minimum daily fiber recommendations of 25 grams for women and 38 grams for men, with the average intake being only around 16 grams per day. Full Plate Living promotes a high-fiber approach to healthy eating through the consumption of fruits, vegetables, beans and legumes, whole grains, nuts and seeds.

A high-fiber diet is associated with decreased risk of cardiovascular disease, coronary artery disease, type 2 diabetes, and gastric, pancreatic, breast and colorectal cancers, as well as overweight and obesity. A high-fiber diet has also been shown to significantly lower total and LDL cholesterol and triglycerides, and it is associated with decreased risk of depression.

There are two ways that individuals and clinicians can access Full Plate Living services and programs. Clinicians can refer patients to the Full Plate Living online membership at fullplateliving.org. Sign-up provides individuals with access to nutrition programs, healthy lifestyles workshops, recipes, a weekly email and a supportive online community. The self-paced nutrition program allows individuals to implement changes at their next meal. Also available at no cost are group program materials, including a facilitator and participant guide. The group program provides a simple-to-follow guide for facilitation through eight sessions. The online membership provides ongoing support when the group-facilitated program ends.

The ACLM program certification designation is offered at three different levels based upon evaluation scores—Honorable Mention, Certified and Gold Certified. The levels are based on factors including years in operation, number of participants, number of organizations using the program, the inclusion of all lifestyle medicine pillars, intervention trials, duration of active treatment, amount of staff contact and follow-up, positive health metrics achieved and participant testimonials.

“ACLM is very proud to recognize the Ardmore Institute of Health’s Full Plate Living as a certified lifestyle medicine program,” said ACLM President Cate Collings, MD, MS, FACC, DipABLM. “More people are living healthier lives and feeling great because of Full Plate Living and the Ardmore Institute’s passion for a future where healthy lifestyles are the preferred method to prevent, treat, and reverse chronic diseases.”

Full Plate Living is the fifth program to earn certification designation from ACLM. The others are: Pivio – the Complete Health Improvement Program, Chanwuyi Lifestyle Medicine Program, The Lift Project and Rochester Lifestyle Medicine Institute’s 15-Day WFPB Jumpstart.

About ACLM

The American College of Lifestyle Medicine is the nation’s medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based, and equitable healthcare delivery system, leading to whole-person health. ACLM educates, equips, empowers and supports its members through quality, evidence-based education, certification, and research to identify and eradicate the root cause of chronic disease, with a clinical outcome goal of health restoration as opposed to disease management.

About Ardmore Institute of Health

Ardmore Institute of Health works for a future where healthy lifestyles will be the preferred method to prevent, treat and reverse chronic diseases such as diabetes and obesity. Since 1947 the organization has been promoting lifestyle change as a means to help people achieve a more healthy and fulfilling life. The Institute is eager to address health inequities and positively influence the social determinants of health in all communities. AIH provides grants to projects that support this mission as well as a free nutrition improvement program called Full Plate Living. Full Plate Living helps people add more whole plant-based foods to meals they’re already eating. It’s a small-step approach that can lead to big health outcomes.

Share article on social media or email:

Houston Emergency Room Physician Raises Alarm About Surge in Respiratory Syncytial Virus (RSV) Infections in Texas


SignatureCare Emergency Center, Plano, TX

SignatureCare Emergency Center, Plano, TX

We are seeing an increase in pediatric and adult RSV infections in our emergency rooms throughout Texas. RSV pops up during the fall and winter cold seasons every year and infects younger kids and adults over 65 years old, but this year, the rate of infection is unprecedented.

As Texans let their guards down and ditch habits that helped keep COVID-19 at bay, a Houston emergency room physician is raising alarm about a potential surge in Respiratory Syncytial Virus or RSV, flu, and COVID infections this winter.

Dr. Hashibul Hannan, a board-certified emergency room physician, and founding member of Houston, TX-based SignatureCare Emergency Center, said this week that SignatureCare ER physicians are seeing a surge in emergency room visits due to RSV infections.

“We are seeing an increase in pediatric and adult RSV infections in our emergency rooms throughout Texas. RSV pops up during the fall and winter cold seasons every year and infects younger kids and adults over 65 years old, but this year, the rate of infection is unprecedented.

“If this continues, coupled with the potential for an increase in COVID and flu infections, Texans could see a ‘tripledemic’ surge this winter,” he said.

Respiratory Syncytial Virus, like COVID-19, is spread when an infected person coughs or sneezes, thereby spreading the virus droplets, which can get into nostrils and eyes, or when someone touches a surface that has the virus on it.

“We can lower the rate at which RSV is spreading just by doing simple things like washing our hands frequently, covering our noses and mouths when we sneeze or cough, using hand sanitizer often, and keeping our distance from others, just like we did at the height of COVID infections,” Hannan added.

He said SignatureCare Emergency Center physicians can diagnose and treat all kinds of viruses, including Rhinovirus, Influenza (flu), Parainfluenza, and RSV.

“We can diagnose and treat all these viruses, including flu and RSV, in our emergency rooms. Our physicians have the experience to quickly diagnose and treat them,” he said.

The Centers for Disease Control and Prevention (CDC) reported this week that Respiratory Syncytial Virus (RSV) infections are increasing exponentially in multiple U.S. regions, with some regions nearing seasonal peak levels.

“CDC surveillance has shown an increase in RSV detections and RSV-associated emergency department visits and hospitalizations in multiple U.S. regions, with some regions nearing seasonal peak levels. Clinicians and public health professionals should be aware of increases in respiratory viruses, including RSV,” a statement posted on the CDC’s website said.

The CDC said that RSV, the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs), can be serious for infants and older adults.

“Respiratory syncytial virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults.

“Each year in the United States, RSV leads to, on average, approximately 58,000 hospitalizations with 100-500 deaths among children younger than 5 years old and 177,000 hospitalizations with 14,000 deaths among adults aged 65 years or older,” according to the CDC.

Symptoms of RSV in children and adults include runny nose, decrease in appetite, coughing, sneezing, fever, and wheezing.

To find the SignatureCare Emergency Center location near you, go to our ER locations page. Our emergency rooms are open 24/7.

About SignatureCare Emergency Center

Houston, TX-based SignatureCare Emergency Center owns 24-hour emergency centers throughout Texas, including nine ER locations in the Houston area (Montrose, Houston Heights, Cypress/FM 1960, Copperfield, Memorial City, Westchase, Bellaire, Mission Bend/Sugar Land, and Stafford), Atascocita/Humble, Killeen, Austin, College Station/Bryan, Paris, Midland, Odessa, Texarkana, Spring, Plano, and Lewisville, TX.

Clean the World Launches Soap Saves Lives Comfort Kits to Provide a Way for Businesses and Employees to Support People Experiencing Homelessness and Economic Hardship


Clean the World launches a new impact product that will enable businesses to pack kits containing hygiene essentials and important resources to individuals experiencing homelessness.

Soap Saves Lives Comfort Kits will provide comfort and care to people across the country who are experiencing homelessness and economic hardship.

Clean the World, a global leader in water, sanitation, hygiene, and sustainability added a new offering to its impact product arsenal: Soap Saves Lives Comfort Kits. Each Soap Saves Lives Comfort Kit consists of a backpack that contains: soap, shampoo, toothbrush, toothpaste, tissues or wipes, deodorant, socks, a snack bar, lip balm, and a personalized note with resources for assistance on the back. The kits will provide comfort and care to people across the country who are experiencing homelessness and economic hardship. Clean the World Foundation, the nonprofit arm of Clean the World, will be distributing the Comfort Kits to people in need through the Fresh Start WASH & Wellness program.

Since 2013, Clean the World has worked with corporate partners to create team-building events, allowing volunteers to come together and assemble hygiene kits and school kits for distribution to individuals living in poverty or to families displaced from their homes due to natural disasters. These events are hosted at offices, in conference settings, and from the comfort of employees’ homes.

“Clean the World is locking arms with the public and private sectors and constantly innovating new impact products in an effort to better the lives of the underserved,” says Shawn Seipler, Founder and CEO, Clean the World. “This new product offering allows organizations to engage their employees and make the world a better place while boosting the morale of their team and increasing customer affinity.”

To launch Soap Saves Lives Comfort Kits to the public, Clean the World hosted a walk-up event at The Linq Promenade, a Caesars Entertainment hotel located on the Las Vegas strip. As part of the launch, 3,000 Comfort Kits were sponsored through a public/private partnership with Clark County Government, Caesars Entertainment, and Caesars Foundation and were assembled by members of the community to help support people experiencing homelessness or economic hardship within the Las Vegas area. The Soap Saves Lives Comfort Kits will be distributed by Clean the World Foundation through the Fresh Start WASH & Wellness program to men, women, and children experiencing homelessness in Clark County, Nevada. In attendance were Clark County Government officials and staff, executives from Caesars Entertainment, Caesars Foundation, Trustees, team members, hotel guests, local social service organizations and wraparound service providers, and the general public.

The Fresh Start WASH & Wellness program in Clark County, NV operates three mobile shower trailers that have provided over 35,000 warm showers to the local unhoused community. Through eight mobile shower trailers, each with an ADA-compliant stall, Clean the World Foundation has distributed close to 46,000 hygiene kits and connected countless individuals to wrap-around services at partner host sites including free mental health or substance abuse assessments, food assistance, help getting identification, clean clothes, healthcare, veterinary care for animals, job placement training, and housing assistance. In 2022, 41 special events were hosted, 173 covid test kits were distributed, and 344 haircuts were given. The continuation of the Fresh Start WASH & Wellness Program provides the opportunity to serve the unhoused with the services needed to ultimately accelerate the successful transition of members of this community to housing, treatment, job placement, and self-sufficiency.

Clark County Government has extended the Fresh Start WASH & Wellness program to provide mobile showers and other hygiene services until June 2023. The Soap Saves Lives Comfort Kits will be delivered to individuals experiencing homelessness in addition to the program providing them with mobile showers, hygiene supplies, mobile COVID-19 testing, immunizations, and vaccinations.

Since 2009, Clean the World has distributed over 72 million bars of soap in 127 countries, along with 5 million hygiene kits to vulnerable people around the world and over 9 million bars of soap to homeless shelters, food pantries, refugee camps, and emergency healthcare facilities during the COVID-19 pandemic.

About Clean the World

Clean the World is a social enterprise dedicated to WASH (water, sanitization, and hygiene) and sustainability. It operates soap recycling centers and offices in Orlando, Montreal, Las Vegas, Hong Kong, Amsterdam, London, and Punta Cana and leads a “Global Hygiene Revolution” to distribute recycled soap and hygiene products from more than 8,100 hotel, resort, and cruise partners. Clean the World Foundation provides WASH (water, sanitization, and hygiene) programming to benefit global communities with high pre-adolescent death rates due to acute respiratory infection (pneumonia) and diarrheal diseases (cholera) – which are two of the top killers of children under the age of five. Since 2009, the foundation has distributed 72 million bars of soap and 5 million hygiene kits in 127 countries. For more information on Clean the World’s many impact products, please visit us online at cleantheworld.org.

Share article on social media or email:

Aeroflow Breastpumps Announces Strategic Partnership with Canopie to Improve Maternal Health Outcomes


By weaving a mental health intervention into lactation support, this first-of-its-kind partnership opens up the door to better, more seamless care delivery for moms.

Customers of the leading breast pump distributor and breastfeeding resource center, Aeroflow Breastpumps can now access free, clinically-effective and on-demand mental health support tools to help reduce postpartum stress, anxiety, and depression—from the comfort and convenience of their home.

App-based mental health care and psychoeducation has been made available through a partnership between Canopie and Aeroflow Breastpumps, providing access to clinically-effective programs that help parents and caregivers manage the highs and lows of parenthood.

This partnership marks a meaningful and progressive move for Aeroflow Breastpumps, a key leader in the insurance-eligible maternal health industry. Research has long shown the correlation between a mom’s breastfeeding relationship and her mental health, with breastfeeding complications increasing the risk of developing a perinatal mood disorder (PMAD) like postpartum depression. By weaving a mental health intervention into lactation support, this first-of-its-kind partnership opens up the door to better, more seamless care delivery for moms.

“Everyday, our team hears from moms who are struggling, says Jennifer Jordan, VP of sales operations at Aeroflow Healthcare. The conversations begin with worries about feeding their baby, but so often they are intertwined with other fears, anxieties, sadness, and frustrations. The clear overlap between breastfeeding and mental health makes our partnership with Canopie a natural fit and enables us to provide a more holistic solution in support of our mission to improve maternal health outcomes from the earliest stages of pregnancy and well into the postpartum journey.”

Canopie launched in December 2020 with their research-based 12-day program that uses clinically-validated therapeutic techniques for preventing and treating depression and anxiety during the perinatal period. Developed alongside top perinatal mental health researchers, the program draws from cognitive behavioral therapy, interpersonal therapy and compassion focused therapy to create high-impact asynchronous sessions and is personalized for each user’s mood goals and stage of parenting. An American Academy of Pediatrics STAR Center resource, Canopie allows users to gain real-time insights into their emotional health and direct them to the most effective tools for managing their current mood.

The application customizes audio and text-based therapeutic programs in English and Spanish framed in terms of parenting challenges like sleep, feeding, and bonding. It also escalates the most vulnerable users to live support.

While as many as one in seven moms in the general population struggle during this period—and as high as one in three of more vulnerable moms, there is still a sense of shame and stigma surrounding feeling low during this time. A digital health intervention like Canopie not only normalizes and helps them navigate these feelings, but also meets parents where they are most comfortable—in the privacy of their own home.

The research shows that digital tools can help prevent up to 50% of perinatal mental health conditions, which not only saves billions of dollars in healthcare, but can also save millions of families tremendous heartache.

Anne Wanlund, co-founder and CEO of Canopie shares, “We are incredibly excited about this partnership with Aeroflow Breastpumps. Our hopes are that by partnering with something as universal as pumping and breastfeeding, we not only help to reduce the stigma associated with seeking mental health support, but we are able to access parents early on in their journey—prenatally, when they are stocking their postpartum supplies. Given that our approach is prevention-based, reaching moms during pregnancy to educate and engage them is essential for reducing the prevalence of PMADs.”

”Untreated mental health conditions account for poor health outcomes for both mom and baby,” says Jordan. “Our focus has always been on expanding the accessibility of insurance-covered supplies and services, and Canopie’s goal of making mental health resources available everywhere, at the tap of the button, aligns perfectly with that mission. Thousands of parents and caregivers will gain access to the Canopie app through our platform, and there are already more plans underway for continued investment in Canopie to expand and deepen mental health support across the perinatal continuum of care.”

This partnership with Aeroflow Breastpumps extends beyond access to digital intervention. Canopie will provide group educational workshops with clinical mental health experts focused on the intersection between mental health and common challenges of parenthood, such as breastfeeding, relationships, identity, and more. Also on the horizon are more integrations of perinatal mental health into the Aeroflow Breastpumps experience.

Since launching their partnership, class engagement from the Aeroflow Breastpumps community has been high and met with enthusiasm, with upwards of 40% of class participants engaging in the Canopie digital intervention.

Wanlund shares, “As new moms ourselves, we knew there was demand for more mental health support when it comes to preparing to feed your baby and feeding your baby, but the challenge has always been making it feel accessible and relatable. When our first classes sold out, we were excited because it meant that the Aeroflow community was hungry—and ready—for this kind of support. Our whole goal is to make mental health support less stigmatized and more available, and we’re honored to be able to do that for this community.”

About Aeroflow Healthcare

Aeroflow Healthcare was founded in Asheville, NC in 2001 and has since grown to become one of the leading durable medical equipment providers nationwide. For three consecutive years, Aeroflow has been ranked on Inc. Magazine’s List of 5000 Fastest Growing Companies. In 2017, Aeroflow was also awarded the HME Excellence Award for Best Home Medical Equipment Provider and has been recognized as a business offering top-notch benefits to employees with the Great Place to Work Award. Aeroflow is an accredited Medicare and Medicaid provider and accepts most commercial insurance. To learn more about Aeroflow Healthcare and getting medical equipment through insurance, visit Aeroflowinc.com.

Share article on social media or email:

Evaluating Clinical Utility of Medical Devices, Diagnostics & Therapeutics with Conjoint Analysis/Clinical Vignettes, Upcoming Webinar Hosted by Xtalks


Register for this webinar as the speakers review clinical utility and describe its importance to payers, physicians, patients and the manufacturers of medical devices, diagnostics/prognostics and therapeutics.

In this webinar, the speakers will discuss the methods used to demonstrate the clinical utility of medical products, and will explain how preference studies, such as conjoint analyses with physician survey data, fit into the armamentarium of techniques used to generate clinical utility evidence. They will provide an overview of conjoint analysis and describe the process of conducting a conjoint analysis study.

The speakers will also present a case study showing how conjoint analysis assessed the clinical utility of a blood-based biomarker test that predicts the risk of kidney disease/decline in Type 2 diabetes mellitus patients. This case study will present typical results of a clinical utility study with conjoint analysis: 1) the relative importance of patient/test attributes for physician monitoring, prescribing and dosing decisions; 2) odds ratios for the impact of low-risk, moderate-risk and high-risk test results on physician decision-making; and 3) value messages supported by the study results.

They will demonstrate that with conjoint analysis they were able to quantify the clinically and statistically significant impact of the novel blood-based biomarker test on patient management decisions, and objectively demonstrate the test’s value to physicians across a range of patient types.

Register for this webinar as the speakers review clinical utility and describe its importance to payers, physicians, patients and the manufacturers of medical devices, diagnostics/prognostics and therapeutics.

Join experts from Veranex, Thomas Goss, Senior Vice President, Commercial Strategy and Market Access; and Lauren Fusfeld, Director, Commercial Strategy and Market Access, for the live webinar on Monday, November 21, 2022, at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Evaluating Clinical Utility of Medical Devices, Diagnostics & Therapeutics with Conjoint Analysis/Clinical Vignettes.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Ayesha Rashid

Tel: +1 (416) 977-6555 x272

Email: arashid@xtalks.com

Share article on social media or email: